Burning Rock Biotech Ltd expected to post a loss of CNY1.49 a share - Earnings Preview

Burning Rock Biotech

11/08/2021 03:54

* Burning Rock Biotech Ltd  BNR.OQ   BNR.O  is expected to show
a rise in quarterly revenue when it reports results on August 11
(estimated). 
* The Guangzhou, Guangdong-based company is expected to report 
 a 29.6% increase in revenue to CNY139 million from CNY107.27
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Burning Rock Biotech
Ltd is for a loss of CNY1.49 per share. For the same quarter
last year, the company reported a loss of CNY2.69 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is $39.94​, about 43.4% above​ its last closing
price of $22.60. ​​​
* Previous quarterly performance (using preferred earnings
measure in Chinese yuan renminbi). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -1.50       -1.50      -1.65     Missed  -10
 Dec. 31 2020  -1.24       -1.24      -1.51     Missed  -21.8
 Sep. 30 2020  -0.76       -0.76      -1.22     Missed  -60.7​
 Jun. 30 2020  -1.40       -1.38      -2.69     Missed  -91.9
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 11 at 02:54 GMT.  All
figures in Chinese yuan renminbi unless otherwise stated